XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net product sales $ 2,654,186 $ 1,562,860 $ 6,941,042 $ 3,504,636
Operating expenses:        
Cost of goods sold $ 104,024 $ 34,908 $ 238,031 $ 142,855
Cost, Product and Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Research and development $ 11,677   $ 16,322 $ 159,347
Selling, general and administrative 3,824,142 $ 3,131,389 10,697,128 8,745,407
Total operating expenses 3,939,843 3,166,297 10,951,481 9,047,609
Loss from operations (1,285,657) (1,603,437) (4,010,439) (5,542,973)
Other income (expense):        
Interest income 99,294 35,558 226,353 112,052
Interest expense (126,027) (126,028) (375,342) (373,973)
Total other expense (26,733) (90,470) (148,989) (261,921)
Net loss $ (1,312,390) $ (1,693,907) $ (4,159,428) $ (5,804,894)
Net loss per share of common stock, basic $ (0.94) $ (6.08) $ (3.01) $ (20.84)
Net loss per share of common stock, diluted $ (0.94) $ (6.08) $ (3.01) $ (20.84)
Weighted-average shares used to compute basic net loss per share 1,399,882 278,558 1,381,703 278,558
Weighted-average shares used to compute diluted net loss per share 1,399,882 278,558 1,381,703 278,558